• Login
    View Item 
    •   Home
    • Articles and other publications by RIVM employees
    • Miscellaneous
    • View Item
    •   Home
    • Articles and other publications by RIVM employees
    • Miscellaneous
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    RIVM Publications RepositoryCommunitiesTitleAuthorsIssue DateSubmit Date

    My Account

    LoginRegister

    Statistics

    Display statistics

    Guidelines on the benefit-risk assessment of the presence of phthalates in certain medical devices covering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    Publisher version
    View Source
    Access full-text PDFOpen Access
    View Source
    Check access options
    Check access options
    Average rating
     
       votes
    Cast your vote
    You can rate an item by clicking the amount of stars they wish to award to this item. When enough users have cast their vote on this item, the average rating will also be shown.
    Star rating
     
    Your vote was cast
    Thank you for your feedback
    Authors
    De Jong, W H
    Type
    Article
    Language
    en
    
    Metadata
    Show full item record
    Title
    Guidelines on the benefit-risk assessment of the presence of phthalates in certain medical devices covering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties.
    Published in
    Regul Toxicol Pharmacol 2020; 111:104546
    DOI
    10.1016/j.yrtph.2019.104546
    PMID
    31830500
    URI
    http://hdl.handle.net/10029/624079
    ae974a485f413a2113503eed53cd6c53
    10.1016/j.yrtph.2019.104546
    Scopus Count
    Collections
    Miscellaneous

    entitlement

    Related articles

    • [Pediatric exposure to endocrine disruptors and carcinogenic, mutagenic or reprotoxic substances by pharmaceutical forms intended for the cutaneous route: Regulatory provisions in France, in Europe, and state of the art of scientific knowledge].
    • Authors: Trouillard A, Sabri A, Prot-Labarthe S, Storme T, Bourrat E, Soulairol I
    • Issue date: 2022 Jul
    • Parental contributions to early embryo development: influences of urinary phthalate and phthalate alternatives among couples undergoing IVF treatment.
    • Authors: Wu H, Ashcraft L, Whitcomb BW, Rahil T, Tougias E, Sites CK, Pilsner JR
    • Issue date: 2017 Jan
    • The effects of phthalates in the cardiovascular and reproductive systems: A review.
    • Authors: Mariana M, Feiteiro J, Verde I, Cairrao E
    • Issue date: 2016 Sep
    • What is an endocrine disruptor?
    • Authors: Monneret C
    • Issue date: 2017 Sep-Oct
    • Phthalates impact human health: Epidemiological evidences and plausible mechanism of action.
    • Authors: Benjamin S, Masai E, Kamimura N, Takahashi K, Anderson RC, Faisal PA
    • Issue date: 2017 Oct 15

    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.